BioSpace News Archive

Luminex Corporation announced that it plans to report results for the third quarter ended September 30, 2019 on Monday, November 4, 2019 after the market close.

BEDFORD, Mass., Oct. 25, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today the oral presentation of preclinical data related to its nuclease-free, homologous recombination-based, in vivo gene editing program for phenylketonuria (PKU) at the European Society of Gene & Cell Therapy (ESGCT) 27th Annual Congress. Homology also presented preclinical data that showed the effect of full and empty capsids on in vivo efficacy with Hom

At a special meeting today, stockholders of Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS) approved the adoption of the Agreement and Plan of Merger (the “Merger Agreement”), dated as of August 7, 2019, by and among Siemens Medical Solutions USA, Inc. (“SMS USA”), Corpus Merger Inc. (“Merger Sub”) and Corindus.

FUJIFILM SonoSite, Inc., specialists in developing cutting-edge, point-of-care ultrasound (POCUS), and part of the greater Fujifilm Healthcare portfolio, will exhibit numerous solutions designed to provide fast, high-quality imaging at the point of care in emergent and critical scenarios at the American College of Emergency Physicians (ACEP19) annual meeting held October 27-29, 2019 at the Colorado Convention Center in Denver, Colorado.

Aesthetic Medical International Holdings Group Limited (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced the pricing of its initial public offering of 2,500,000 American Depositary Shares

Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage bispecific antibody company developing Biclonics®, innovative full-length human bispecific antibody therapeutics, today announced that data from its MCLA-128 and MCLA-129 programs will be presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics being held October 26-30, 2019 in Boston, Massachusetts.

The American College of Prosthodontists’ 2019 Annual Session will be in Miami Beach Oct. 30-Nov. 2

Generex Biotechnology Corporation announced the results of the annual meeting of the Company’s stockholders held on October 25, 2019.

As the agency responsible for ensuring the safety and effectiveness of all medical devices, the U.S. Food and Drug Administration has been closely monitoring the supply chain effects of closures and potential closures of certain large-scale sterilization facilities that use a gas called ethylene oxide to sterilize medical devices prior to their use.

The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which provide skilled nursing and assisted living services, physical, occupational and speech therapies and other rehabilitative and healthcare services, announced today that it expects to issue its third quarter 2019 financial results on Wednesday, October 30, 2019